Prosight Management’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-59,542
| Closed | -$1.03M | – | 60 |
|
|
2024
Q2 | $1.03M | Sell |
59,542
-5,458
| -8% | -$94.4K | 0.31% | 39 |
|
|
2024
Q1 | $1.45M | Sell |
65,000
-128,134
| -66% | -$2.86M | 0.4% | 36 |
|
|
2023
Q4 | $3.54M | Buy |
193,134
+2,016
| +1% | +$37K | 1.42% | 17 |
|
|
2023
Q3 | $3.32M | Sell |
191,118
-51,739
| -21% | -$898K | 1.05% | 25 |
|
|
2023
Q2 | $4.42M | Buy |
242,857
+117,619
| +94% | +$2.14M | 1.29% | 24 |
|
|
2023
Q1 | $2.15M | Sell |
125,238
-5,699
| -4% | -$97.7K | 1.02% | 28 |
|
|
2022
Q4 | $3.04M | Buy |
130,937
+80,016
| +157% | +$1.86M | 1.66% | 20 |
|
|
2022
Q3 | $1.13M | Buy |
+50,921
| New | +$1.13M | 0.61% | 31 |
|